Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ERS Genomics
Dublin, Leinster, Irelandersgenomics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
ERS Genomics provides non-exclusive licenses to foundational CRISPR/Cas9 patents co-owned by Nobel laureate Emmanuelle Charpentier. The company’s IP covers a broad range of applications across life sciences research tools, drug discovery platforms, bioproduction processes, animal health products, agriculture/food production innovations, diagnostics technologies and synthetic biology. It does not develop its own clinical products or services but enables others to do so via access to essential genome-editing rights. Over 150 licensees worldwide—including major pharma/biotech companies—use this technology for diverse R&D purposes outside direct human therapeutics.
- Therapeutic areas
- Other
- Modalities
- CRISPR-based therapy (licensing only; not developing therapeutics)Gene editing technology (platform licensing)Guide RNA therapy (as part of platform IP)Synthetic biology applications (as part of platform IP)
- Industry
- Drug Discovery Services
02
Partnerships
Santa Cruz BiotechnologyMedicines Discovery CatapultApplied StemCellCytosurge AG
Beyond the preview
Go deeper on ERS Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ERS Genomics.